This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to the prime contractor RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company. The contract, valued at $538,493.10, is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to support nuclear medicine imaging procedures at VA medical facilities. RLS (USA) Inc. holds several federal IDV contracts with the VA...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense, to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The BPA has a ceiling value of $350,000.00 and a performance period from February 17, 2022 to February 16, 2027. The primary contracted products are Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical used in nuclear medicine imaging procedures. The BPA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single award indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical services and support. The contract has a potential value of $483,000 and period of performance through September 30, 2022. No set-aside was used for this award. Under the contract, the prime contractor has been issued two delivery orders. The first was for an...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 21 has awarded an Indefinite Delivery Contract (IDC) worth up to $1,200,000 to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to VA medical centers and military treatment facilities. The initial task order under this IDC is valued at $179,605.38 and covers the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to RLS USA Inc., a foreign-owned, for-profit radiopharmacy company. The single-award IDV has a ceiling value of $4,998,603.38 and a period of performance through September 17, 2029. It covers the provision of a range of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a blanket purchase agreement to Advanced Accelerator Applications USA Inc. to provide Ga-68 Netspot radiopharmaceuticals and related nuclear medicine services. The BPA has a potential value of $244,000 and period of performance through December 2023. Two calls were placed against the BPA for services in Pittsburgh and Philadelphia, with values of $5,600 and $0 respectively and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded an indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical gallium Ga 68 dotatate. The single award IDV has a potential value of $1,015,000 and a period of performance through January 2026. Under the IDV, the awardee has received a $126,000 firm fixed price delivery order to supply gallium Ga 68 dotatate for nuclear medicine...
RLS USA Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide radiopharmaceutical products. The potential value of the contract is $1,162,500. No set-aside designation was applied. Under the contract, RLS USA Inc. received two delivery orders to date for radiopharmaceutical supplies. The first delivery order, valued at $244,564.67, was awarded on August 2, 2022 for a performance...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to RLS USA Inc. to provide non-PET radiopharmaceuticals in support of nuclear medicine services. The contract established a potential value of $733,420.11 over its period of performance from October 2021 through September 2024. Delivery orders issued against this contract included awards of $251,729.90, $244,402.04, and $650,585.28 to RLS USA Inc. for...
This federal contract IDV award is a single-award indefinite delivery contract between the U.S. Department of Veterans Affairs (VA) and the prime contractor RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a total ceiling value of $249,500 and a performance period ending on March 31, 2025. Under this IDV, RLS (USA) Inc. will supply a variety of non-PET radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers and military...